NCT05183841View on ClinicalTrials.gov

Bronchodilators on the Exercise Capacity of Bronchiectasis Patients

NAEnrolling by invitationINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 14, 2022

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2025

Conditions
Bronchiectasis Adult
Interventions
DRUG

Bronchodilator (Ipratropium and Fenoterol)

8 puffs of Ipratropium (20mcg) and Fenoterol (50mcg) via an inhaler device with a spacer (30 seconds interval between puffs) in 5 tidal volume breaths each puff.

OTHER

Placebo

8 puffs of placebo via an inhaler device with a spacer (30 seconds interval between puffs) in 5 tidal volume breaths each puff.

Trial Locations (3)

01246903

Celso Ricardo Fernandes de Carvalho, São Paulo

05360000

Clinical Hospital of Sao Paulo University Medical School (HCFMUSP), São Paulo

Clinical Hospital of Sao Paulo University Medical School, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER